We are live on ! Find out more
CMP

Coston McIsaac & Partners Portfolio holdings

AUM $443M
1-Year Est. Return 6.68%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+6.68%
3 Year Est. Return
+29.7%
5 Year Est. Return
10 Year Est. Return
AUM
$257K
AUM Growth
-$219M
Cap. Flow
+$5.62M
Cap. Flow %
2,186.9%
Top 10 Hldgs %
30.54%
Holding
874
New
93
Increased
344
Reduced
43
Closed
22

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.51%
2 Consumer Discretionary 8.85%
3 Technology 7.24%
4 Utilities 6.79%
5 Financials 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSR
551
DELISTED
Fisker Inc.
FSR
-1
Closed
WE
552
DELISTED
WeWork Inc.
WE
$0 ﹤0.01%
+2
New +$187
APPH
553
DELISTED
AppHarvest, Inc. Common Stock
APPH
$0 ﹤0.01%
100
+50
+100% +$65
TWTR
554
DELISTED
Twitter, Inc.
TWTR
-214
Closed -$9K
CTXS
555
DELISTED
Citrix Systems Inc
CTXS
-294
Closed -$30K
PGN
556
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
$0 ﹤0.01%
10

Similar funds

Coston McIsaac & Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Coston McIsaac & Partners held 874 positions worth $257K, down 100% from $219M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Coston McIsaac & Partners deployed $5.62M of net new capital in Q4 2022, opening 93 new positions and adding to 344 existing holdings. Its largest new stake was State Street SPDR Portfolio Short Term Corporate Bond ETF: 7,916 shares worth $232.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was ExxonMobil, an estimated $479K trimmed.

  • Coston McIsaac & Partners's largest Q4 2022 buy was State Street SPDR Portfolio Short Term Corporate Bond ETF: 7,916 shares worth $232.
  • Coston McIsaac & Partners added most to Vanguard Dividend Appreciation ETF in Q4 2022, an estimated $1.81M increase.
  • Coston McIsaac & Partners's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $479K.
  • Coston McIsaac & Partners fully exited Apellis Pharmaceuticals in Q4 2022, selling an estimated $136K.
  • Coston McIsaac & Partners's ten largest holdings make up 31% of its $257K portfolio in Q4 2022.
  • Coston McIsaac & Partners opened 93 new positions and closed 22 in Q4 2022.
  • Coston McIsaac & Partners's portfolio value fell 100% quarter-over-quarter to $257K.

Based on Coston McIsaac & Partners's 13F filing for Q4 2022, filed 9 Feb 2023.